{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:26:03Z","timestamp":1773131163306,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcin.2026.01.278","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:51:18Z","timestamp":1773082278000},"page":"552-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous Coronary Intervention for Stent Thrombosis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2316-3705","authenticated-orcid":false,"given":"Manel","family":"Sabat\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sabat\u00e9-Tormos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcin.2026.01.278_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","article-title":"Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.jcin.2026.01.278_bib2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2026.01.278_bib3","article-title":"Underlying mechanisms of second-generation drug eluting stent thrombosis: an optical coherence tomography study.","author":"Durmaz","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jcin.2026.01.278_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jcin.2026.01.278_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jcin.2026.01.278_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jacc.2020.12.059","article-title":"10-Year follow-up of patients with everolimus-eluting versus bare-metal stents after ST-segment elevation myocardial infarction","volume":"77","author":"Brugaletta","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jcin.2026.01.278_bib7","first-page":"541","article-title":"Contemporary trends, characteristics, and outcomes of patients undergoing percutaneous coronary intervention for stent thrombosis","volume":"19","author":"Elbadawi","year":"2026","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jcin.2026.01.278_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","volume":"122","author":"Kimura","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jcin.2026.01.278_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2007.10.057","article-title":"Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio Espanol Sobre Trombosis de Stents Farmacoactivos)","volume":"51","author":"de la Torre-Hernandez","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jcin.2026.01.278_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jcin.2026.01.278_bib11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jcin.2018.02.029","article-title":"Neoatherosclerosis in patients with coronary stent thrombosis: findings from optical coherence tomography imaging (a report of the PRESTIGE Consortium)","volume":"11","author":"Joner","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2026.01.278_bib12","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","article-title":"Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial","volume":"17","author":"Kerkmeijer","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2026.01.278_bib13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4244\/EIJ-D-19-00773","article-title":"Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study","volume":"15","author":"Brugaletta","year":"2020","journal-title":"EuroIntervention"},{"issue":"23","key":"10.1016\/j.jcin.2026.01.278_bib14","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jcin.2026.01.278_bib15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jcin.2025.04.048","article-title":"Magnesium-based resorbable scaffold vs sirolimus-eluting stent in STEMI patients: 5-year results of the MAGSTEMI trial","volume":"18","author":"Sabat\u00e9","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"10261","key":"10.1016\/j.jcin.2026.01.278_bib16","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcin.2026.01.278_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2025.10.027","article-title":"Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial","volume":"87","author":"Tao","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2026.01.278_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2023.01.007","article-title":"Comparing a strategy of sirolimus eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: design and rationale of the SELUTION DeNovo trial","volume":"258","author":"Spaulding","year":"2023","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879826003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879826003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:51:49Z","timestamp":1773082309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879826003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1936879826003900"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2026.01.278","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous Coronary Intervention for Stent Thrombosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2026.01.278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.11.045","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}